Stock PHGN34 PHILIPS NV
Add to a list
To use this feature you must be a member
Log inSign up

Financials Philips NV Sao Paulo

Equities

PHGN34

BRPHGNBDR002

Advanced Medical Equipment & Technology

Delayed Sao Paulo
Other stock markets
 12:49:40 14/06/2024 am IST 		5-day change 1st Jan Change
139 BRL -2.17% Intraday chart for Philips NV 0.00% +24.77%
02:02pm Royal Philips' Largest Shareholder Exor Increases Stake to 17.51% MT
12:28pm Philips: holding company Exor increases its stake CF

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 38,000 38,828 27,462 12,091 18,834 22,181 - -
Enterprise Value (EV) 1 42,022 42,536 32,138 18,178 24,651 27,110 26,803 25,826
P/E ratio 33.5 x 33.9 x 8.98 x -7.69 x -41.3 x 108 x 21.8 x 17.6 x
Yield 1.95% 1.94% 2.59% 6.07% 4.03% 3.51% 3.66% 4.03%
Capitalization / Revenue 1.95 x 1.99 x 1.6 x 0.68 x 1.04 x 1.19 x 1.13 x 1.08 x
EV / Revenue 2.16 x 2.18 x 1.87 x 1.02 x 1.36 x 1.45 x 1.36 x 1.25 x
EV / EBITDA 11.6 x 11.5 x 10.8 x 7.89 x 8.66 x 9.06 x 7.9 x 7.06 x
EV / FCF 39.9 x 23 x 35.7 x -18.9 x 15.6 x 22.6 x 31.2 x 16.5 x
FCF Yield 2.51% 4.35% 2.8% -5.29% 6.42% 4.42% 3.2% 6.08%
Price to Book 3.08 x 3.34 x 1.97 x 0.93 x 1.61 x 1.91 x 1.83 x 1.75 x
Nbr of stocks (in thousands) 9,62,448 9,58,166 9,05,498 9,32,751 9,23,773 9,32,766 - -
Reference price 2 39.48 40.52 30.33 12.96 20.39 23.78 23.78 23.78
Announcement Date 28/01/20 25/01/21 24/01/22 30/01/23 29/01/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 19,482 19,535 17,156 17,827 18,169 18,707 19,681 20,602
EBITDA 1 3,615 3,709 2,985 2,305 2,845 2,992 3,392 3,659
EBIT 1 2,563 2,570 2,054 1,318 1,921 2,164 2,413 2,579
Operating Margin 13.16% 13.16% 11.97% 7.39% 10.57% 11.57% 12.26% 12.52%
Earnings before Tax (EBT) 1 1,529 1,490 509 -1,731 -526 311 1,562 1,950
Net income 1 1,167 1,187 3,319 -1,608 -466 227.5 1,169 1,414
Net margin 5.99% 6.08% 19.35% -9.02% -2.56% 1.22% 5.94% 6.87%
EPS 2 1.179 1.194 3.379 -1.685 -0.4932 0.2201 1.093 1.349
Free Cash Flow 1 1,053 1,852 900 -961 1,582 1,198 858.7 1,569
FCF margin 5.4% 9.48% 5.25% -5.39% 8.71% 6.41% 4.36% 7.62%
FCF Conversion (EBITDA) 29.13% 49.93% 30.15% - 55.61% 40.06% 25.32% 42.88%
FCF Conversion (Net income) 90.23% 156.02% 27.12% - - 526.83% 73.44% 110.93%
Dividend per Share 2 0.7711 0.7868 0.7868 0.7868 0.8219 0.8348 0.8703 0.9585
Announcement Date 28/01/20 25/01/21 24/01/22 30/01/23 29/01/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 8,554 8,057 4,156 4,944 3,918 4,177 8,095 4,310 5,422 4,167 4,470 4,471 5,062 4,138 4,471 4,638 5,472 -
EBITDA - - - - - - - - - - - - 896 - 673.3 725.2 1,065 -
EBIT 662 - 512 - 243 216 459 209 651 359 453 457 653 - 467.5 582.6 831.3 -
Operating Margin 7.74% - 12.32% - 6.2% 5.17% 5.67% 4.85% 12.01% 8.62% 10.13% 10.22% 12.9% - 10.46% 12.56% 15.19% -
Earnings before Tax (EBT) - - - - - - - - 7 - - 130 - - - - - -
Net income 1 246 - 2,973 157 -151 -22 -173 -1,330 -106 - 72 88 39 -999 679.2 204.8 288.6 -
Net margin 2.88% - 71.54% 3.18% -3.85% -0.53% -2.14% -30.86% -1.95% - 1.61% 1.97% 0.77% -24.14% 15.19% 4.41% 5.27% -
EPS 2 - - 2.999 0.1666 -0.1574 -0.0185 - -1.388 -0.1111 - 0.0774 0.0870 0.0387 -1.064 0.7515 0.2271 0.3133 -
Dividend per Share 2 - - - 0.7868 - - - - 0.7868 - - - - - - - - -
Announcement Date 20/07/20 26/07/21 18/10/21 24/01/22 25/04/22 25/07/22 25/07/22 24/10/22 30/01/23 24/04/23 24/07/23 23/10/23 29/01/24 29/04/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 4,022 3,708 4,676 6,087 5,817 4,929 4,622 3,644
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.113 x 0.9997 x 1.566 x 2.641 x 2.045 x 1.647 x 1.363 x 0.996 x
Free Cash Flow 1 1,053 1,852 900 -961 1,582 1,198 859 1,569
ROE (net income / shareholders' equity) 14.9% 9.7% 25.3% 6.1% 9.08% 11.2% 12.9% 13.6%
ROA (Net income/ Total Assets) 6.94% 6.63% 5.1% 2.74% 3.82% 2.93% 3.68% 4.66%
Assets 1 16,817 17,906 65,043 -58,658 -12,197 7,758 31,780 30,336
Book Value Per Share 2 12.80 12.10 15.40 13.90 12.70 12.40 13.00 13.60
Cash Flow per Share 2 2.020 2.800 1.660 -0.1800 2.250 1.750 1.710 2.470
Capex 1 978 924 729 788 554 962 988 1,040
Capex / Sales 5.02% 4.73% 4.25% 4.42% 3.05% 5.14% 5.02% 5.05%
Announcement Date 28/01/20 25/01/21 24/01/22 30/01/23 29/01/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Philips NV

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
23.78 EUR
Average target price
25.36 EUR
Spread / Average Target
+6.65%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+5.40% 21TCr
DANAHER CORPORATION Stock Danaher Corporation
+10.39% 19TCr
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+30.89% 16TCr
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+33.61% 11TCr
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+3.46% 6.4TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+1.51% 4.88TCr
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-3.44% 3.93TCr
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+2.08% 3.6TCr
RESMED, INC. Stock ResMed, Inc.
+7.36% 2.7TCr
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. PHIA Stock
  4. PHGN34 Stock
  5. Financials Philips NV